Christian Medical College, Vellore, India.
Christian Medical College, Vellore, India.
Reprod Biomed Online. 2018 Jun;36(6):705-710. doi: 10.1016/j.rbmo.2018.03.016. Epub 2018 Apr 6.
It is a matter of interest whether pregnancies with the use of donor sperm are associated with a higher risk of adverse perinatal outcomes compared with partner sperm. Anonymized data were obtained from the Human Fertilization & Embryology Authority. Data from 1991 to 2011 involving a total of 95,787 singleton births (4523 with donor sperm and 91,264 with partner sperm) following fresh IVF/intracytoplasmic sperm injection (ICSI) were analysed to compare perinatal outcomes of preterm birth (PTB), low birthweight (LBW) and high birthweight (HBW). The risk of LBW was significantly lower (adjusted odds ratio [aOR] 0.88, 95% confidence interval [CI]: 0.79-0.99) following donor sperm versus partner sperm IVF/ICSI. There was no significant difference in the risk of PTB (aOR 0.93, 95% CI: 0.83-1.04), early PTB (aOR 0.86, 95% CI: 0.67-1.11), very LBW (aOR 0.95, 95% CI: 0.75-1.20), HBW (aOR 1.09, 95% CI: 0.98-1.21) and very HBW (aOR 1.15, 95% CI: 0.90-1.45) following donor sperm versus partner sperm IVF/ICSI. The current study did not demonstrate an increased risk of adverse perinatal outcomes following donor sperm compared with partner sperm IVF/ICSI treatment.
使用供精进行妊娠是否与使用伴侣精子相比具有更高的围产期不良结局风险,这是一个值得关注的问题。从人类受精和胚胎管理局获得了匿名数据。对 1991 年至 2011 年期间共 95787 例新鲜体外受精/胞浆内单精子注射(IVF/ICSI)后单胎分娩(4523 例使用供精,91264 例使用伴侣精子)的数据进行分析,以比较早产(PTB)、低出生体重(LBW)和高出生体重(HBW)的围产期结局。与伴侣精子 IVF/ICSI 相比,供精 IVF/ICSI 的 LBW 风险显著降低(调整后的优势比[aOR]0.88,95%置信区间[CI]:0.79-0.99)。PTB(aOR 0.93,95%CI:0.83-1.04)、早期 PTB(aOR 0.86,95%CI:0.67-1.11)、非常 LBW(aOR 0.95,95%CI:0.75-1.20)、HBW(aOR 1.09,95%CI:0.98-1.21)和非常 HBW(aOR 1.15,95%CI:0.90-1.45)的风险在供精与伴侣精子 IVF/ICSI 后无显著差异。本研究未显示与使用伴侣精子 IVF/ICSI 相比,使用供精进行 IVF/ICSI 治疗后围产期不良结局的风险增加。